Braeden Anderson
- Indexed articles, last 90 days
- 7
- Latest publication
- Aug 31, 2026
- Outlet visibility, for Mondaq
- Top 500K sites
- Earliest in this view
- Jul 27, 2026
Latest articles
CFTC Proposes New CPO Registration Exemption For SEC-Registered Advisers (opens the original)
Read excerpt
The CFTC has proposed a new registration exemption for SEC-registered investment advisers operating specified commodity pools. The headline relief is straightforward: a qualifying adviser could cease registering as a commodity pool operator for a qualifying pool, and related commodity trading adviser relief would follow. The regulatory trade is not. Proposed Regulation 4.13(a)(4) would replace CPO registration with a defined combination of SEC oversight, offering restrictions, participant-eligib
SEC Semiannual Reporting Proposal Would Give Issuers Flexibility, But Quarterly Reporting May Remain The Market Standard (opens the original)
Read excerpt
The SEC’s proposal to permit semiannual reporting would give public companies greater flexibility over the timing of their periodic reports. It may not, however, materially displace quarterly reporting as the prevailing market practice. On May 5, 2026, the SEC proposed amendments that would allow domestic reporting companies to elect to file a new Form 10-S covering the first six months of the fiscal year, together with the existing annual report on Form 10-K, in lieu of filing Forms 10-Q for ea
Clinical-Trial Prediction Markets Have Arrived. Their Credibility Will Depend On Who Is Allowed To Trade. (opens the original)
Read excerpt
Clinical-trial prediction markets will test whether federal derivatives regulation can keep pace with a market in which information asymmetry is both the product and the principal risk. Kalshi recently launched a pilot suite of markets tied to late-stage clinical trials and decisions by the U.S. Food and Drug Administration. The contracts allow participants to trade on questions such as whether a Phase 3 trial will meet its primary endpoint or whether the FDA will approve a particular drug. Kals
Fifteen Years After Dodd-Frank, What Do The Data Tell Us About The Swaps Market? (opens the original)
Read excerpt
The Dodd-Frank Act substantially reconstructed the legal architecture governing the over-the-counter derivatives markets. More than fifteen years later, however, an important empirical question remains unresolved: what effect did that reconstruction have on the actual use of swaps? Has Dodd-Frank Improved or Impeded Swap Markets?.1 Readers interested in derivatives regulation should read Professor Beylin’s original essay and underlying paper in full. The research is careful, data-intensive, and
SEC Commissioner Peirce Flags Securities-Law Risks For Crypto Vaults And Onchain Lending (opens the original)
Read excerpt
SEC Commissioner Hester Peirce has identified investment-contract, investment-company, note, and investment-adviser issues that may arise from crypto vaults and onchain lending strategies. The legal analysis extends beyond the classification of the deposited crypto asset. Vault structure, managerial control, portfolio composition, lending terms, and compensation arrangements may independently bring a product within the federal securities laws. A crypto asset’s status as a non-security does not r
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Mondaq, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.